Filing Details
- Accession Number:
- 0000899243-20-000660
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-06 21:30:20
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-06 21:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779990 | Thomas Michael Henderson | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-01-02 | 1,500 | $32.69 | 180,737 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-02 | 2,002 | $33.61 | 178,735 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-02 | 115 | $34.45 | 178,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-03 | 332 | $32.28 | 178,288 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-03 | 26 | $33.00 | 178,262 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.
- Represents the weighted average sale price of the shares sold from $32.15 to $33.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5, 6 and 7.
- Includes 1,470 shares acquired by the Reporting Person on December 31, 2019 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
- Represents the weighted average sale price of the shares sold from $33.16 to $34.15 per share.
- Represents the weighted average sale price of the shares sold from $34.34 to $35.17 per share.
- Represents the weighted average sale price of the shares sold from $31.87 to $32.86 per share.
- Represents the weighted average sale price of the shares sold from $32.91 to $33.14 per share.
Billionaire Hedge Funds
